Use cases
One platform. Many indications.
The Digital Gut Twin™ is a horizontal substrate for precision medicine. The same continuous physiology that explains a GLP-1 responder also explains an IBD flare, a perimenopausal metabolic shift, or the earliest signal of decline.
GLP-1 optimization
Adherence, side-effect mitigation, efficacy - and maintaining results after taper.
- Gastric emptying half-time
- Small-bowel transit
- Postprandial pH recovery
- Colonic fermentation depth
GLP-1s work by slowing gastric emptying and rewiring satiety signaling. The same mechanism is what produces nausea, reflux, constipation, and the dropout curve that defines the category. Today, every dose decision is made blind to that mechanism.
The Digital Gut Twin™ reads gastric and small-bowel emptying, transit, fermentation, and circadian thermogenesis directly. We can see who is responding, who is over-suppressed, who is mal-absorbing, and what eating patterns and timing rescue tolerability without sacrificing efficacy.
The most important problem in the category is what happens after the drug stops. Maintaining results requires rebuilding the metabolic and motility patterns the drug was overriding. The twin is the only way to measure that rebuild - and to coach against it in real time.
Metabolism & weight
Glycemic response, fermentation patterns, and the gut–liver axis as a closed loop.
- Bile acid timing proxy
- Postprandial ORP shift
- SCFA fermentation depth
- Circadian thermogenesis
CGM showed the world that glucose is personal. But glucose is downstream - by the time it moves, the relevant biology has already happened in the gut. Bile timing, gastric output, ileal nutrient sensing, and short-chain fatty acid production determine the curve a CGM only describes.
Pairing continuous gut physiology with glucose, sleep, and activity closes the loop on metabolic personalization for the first time. The twin tells you not just what your glucose did, but why - and what specifically to change.
Gut health, IBS & IBD
Functional and inflammatory gut conditions measured continuously, not retrospectively.
- Segmental transit variability
- Ileocecal ORP delta
- Small-bowel pH stability
- Nocturnal motility patterning
IBS, IBD, SIBO, and functional dyspepsia are managed today on symptom diaries, intermittent endoscopy, and lagging biomarkers. Flares are reconstructed after the fact; triggers are guessed.
Continuous in-vivo physiology turns this into a forward-looking discipline. Motility variability predicts IBS-class transitions. Ileal ORP collapse and small-bowel pH abnormalities flag SIBO and inflammatory shifts before symptoms peak. The twin gives clinicians and patients a real-time control surface for conditions that have only ever been observed in arrears.
Women's health
PMOS, endometriosis, the cycle and menopause - all read through the gut.
- Metabolic–endocrine pattern dynamics (PMOS)
- Estrobolome fermentation profile
- Cycle-phase motility & pH shift
- Postmenopausal estrogen-recycling drift
In May 2026 PCOS was renamed PMOS - Polyendocrine Metabolic Ovarian Syndrome - codifying what the data has long shown: the condition affecting roughly one in eight women is driven by insulin resistance and metabolic-endocrine dysregulation, not by ovarian cysts.
Endometriosis is heading the same way. Elevated triglyceride-glucose index and insulin/IGF-1 signaling now track with disease risk and severity, and the estrobolome - the gut microbes whose β-glucuronidase enzymes recycle estrogen back into circulation - is increasingly implicated in its pathogenesis. A metabolically modifiable disease, not a purely gynecological one.
After menopause the ovaries go quiet, but the estrobolome does not. It becomes the dominant regulator of circulating estrogen, and the metabolic drivers behind PMOS and endometriosis carry through - directly shaping bone, cardiometabolic and cognitive trajectory.
The Digital Gut Twin is designed to capture the upstream chemistry behind all of this: motility, pH, and fermentation dynamics that shift with metabolic and hormonal state across the cycle and the menopausal transition.
Longevity
Circadian alignment, inflammation load, and metabolic flexibility - tracked over years.
- Circadian amplitude
- Chronic inflammatory tone
- Postprandial recovery slope
- Year-over-year drift
The most credible longevity signal is not a single biomarker but the trajectory of physiology over time: how flexibly the system responds, how aligned it is to its circadian clock, how low the chronic inflammatory baseline sits.
All three are gut-readable. Core temperature from inside the gut is the cleanest circadian signal in the body. ORP and fermentation depth indicate inflammatory and microbial load. Postprandial recovery curves index metabolic flexibility. The twin turns longevity from a stack of supplements into a measured, longitudinal practice.
Preventative care
The earliest detectable shifts in physiology - before disease, before symptoms.
- Drift detection
- Cohort-relative deviation
- Pre-symptomatic clustering
- Trajectory modeling
Most chronic disease is preceded by years of physiological drift that no current screen catches. The gut is unusually well-positioned to surface that drift early: it is metabolically central, immunologically active, and now - for the first time - continuously measurable.
Population-scale longitudinal twins create the substrate for genuine early detection: the metabolic, inflammatory, and motility patterns that precede diagnosis, learned across cohorts and applied to the individual.
Build with us
Partners, pilots, and the seed round.
We are talking with GLP-1 telehealth platforms, women's health clinics, IBD centers, and longevity programs about pilot cohorts. And we are raising the seed round that funds them.